滨医附院成为山东省肿瘤临床研究协作组（SCOG）成员单位

Core Viewpoint - The establishment of the Shandong Clinical Research Oncology Group (SCOG) aims to integrate high-quality medical resources and research capabilities across Shandong province to enhance cancer treatment and research, ultimately improving patient outcomes and facilitating medical innovation [3]. Group 1: Establishment and Objectives - The SCOG was launched to create a standardized, regulated, and quality-controlled clinical research platform to tackle cancer challenges and improve treatment levels [3]. - The inclusion of Binzhou Medical University Affiliated Hospital as a founding member signifies its formal integration into a high-level provincial cancer clinical research network [2]. Group 2: Clinical Research Achievements - Binzhou Medical University Affiliated Hospital has conducted nearly 500 clinical trials, with over 150 focused on various types of cancer, including lung, gastric, colorectal, and breast cancers, involving cutting-edge treatments such as immunotherapy and targeted therapy [3]. - These studies have provided critical data for drug development and have directly benefited thousands of patients by offering access to innovative treatments, effectively extending their lives and improving their quality of life [3]. Group 3: Future Plans and Responsibilities - The hospital plans to actively engage in provincial multi-center clinical research and conduct specialized studies on regionally prevalent cancers [4]. - It will adhere to the standardized treatment and quality control standards set by the SCOG, aiming to enhance the uniformity of high-quality medical resources [4]. - The hospital will focus on talent development and academic exchange to continuously improve research innovation capabilities, ultimately benefiting cancer patients and contributing to the health of the nation [4].